Posthospitalization COVID-19 cognitive deficits at 1 year are global and associated with elevated brain injury markers and gray matter volume reduction

Greta K Wood, Brendan F Sargent, Zain-Ul-Abideen Ahmad, Kukatharmini Tharmaratnam, Cordelia Dunai, Franklyn N Egbe, Naomi H Martin, Bethany Facer, Sophie L Pendered, Henry C Rogers, Christopher Hübel, Daniel J van Wamelen, Richard A I Bethlehem, Valentina Giunchiglia, Peter J Hellyer, William Trender, Gursharan Kalsi, Edward Needham, Ava Easton, Thomas A JacksonColm Cunningham, Rachel Upthegrove, Thomas A Pollak, Matthew Hotopf, Tom Solomon, Sarah L Pett, Pamela J Shaw, Nicholas Wood, Neil A Harrison, Karla L Miller, Peter Jezzard, Guy Williams, Eugene P Duff, Steven Williams, Fernando Zelaya, Stephen M Smith, Simon Keller, Matthew Broome, Nathalie Kingston, Masud Husain, Angela Vincent, John Bradley, Patrick Chinnery, David K Menon, John P Aggleton, Timothy R Nicholson, John-Paul Taylor, Anthony S David, Alan Carson, Ed Bullmore, COVID-CNS Consortium

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

6 Citations (Scopus)

Abstract

The spectrum, pathophysiology and recovery trajectory of persistent post-COVID-19 cognitive deficits are unknown, limiting our ability to develop prevention and treatment strategies. We report the 1-year cognitive, serum biomarker and neuroimaging findings from a prospective, national study of cognition in 351 COVID-19 patients who required hospitalization, compared with 2,927 normative matched controls. Cognitive deficits were global, associated with elevated brain injury markers and reduced anterior cingulate cortex volume 1 year after COVID-19. Severity of the initial infective insult, postacute psychiatric symptoms and a history of encephalopathy were associated with the greatest deficits. There was strong concordance between subjective and objective cognitive deficits. Longitudinal follow-up in 106 patients demonstrated a trend toward recovery. Together, these findings support the hypothesis that brain injury in moderate to severe COVID-19 may be immune-mediated, and should guide the development of therapeutic strategies.

Original languageEnglish
Article number101417
JournalNature Medicine
Volume31
Issue1
Pages (from-to)245–257
Number of pages13
ISSN1078-8956
DOIs
Publication statusPublished - Jan 2025

Fingerprint

Dive into the research topics of 'Posthospitalization COVID-19 cognitive deficits at 1 year are global and associated with elevated brain injury markers and gray matter volume reduction'. Together they form a unique fingerprint.

Cite this